Continuous Monitoring of Left Atrial Pressure during MitraClip, Regardless Echocardiography

The aim of this study was to assess the use of measuring left atrial pressure to complement transesophageal echocardiography and doppler imaging.

MitraClip: ¿debemos intervenir antes a nuestros pacientes?Procedure efficacy is measured in the cath lab by echocardiography. However, these measurements are operator dependent and might be influenced by left ventricular function and changes in left atrial compliance.

 

The study looked at continuous left sided pressure in 50 patients undergoing MitraClip. These measurements included left atrial V-wave pressure, and left atrial mean, systolic, and end-diastolic pressures. Left atrial pressures were indexed to left ventricular pressures to compensate for variations in afterload during procedure.


Read also: TCT 2018 | TriValve: Mitraclip for the Tricuspid Valve.


70% of patients had degenerative mitral regurgitation. Mitral regurgitation grade by echocardiography decreased from 3+ to 0+, and atrial V-wave (p<0.001), mean left atrial pressure (p=0.007), end diastolic pressure (p=0.001) and all left atrial pressures indexed values also decreased after MitraClip.

 

Intra-procedural increase of mean left atrial pressure was associated to a smaller number of rehospitalizations for cardiac failure and more chances to reach functional class III or IV at follow-up. These events could not be predicted by post procedure 2+ mitral regurgitation.

 

Conclusions

This study shows the value of continued real-time monitoring of left atrial pressure to predict events after treating mitral regurgitation with MitraClip. An increase in left atrial mean pressure is a predictor of worse prognosis at short term, regardless echocardiographic findings.

 

Original title: Continuous Direct Left Atrial Pressure. Intraprocedural Measurement Predicts Clinical Response Following MitraClip Therapy.

Reference: Shingo Kuwata et al. J Am Coll Cardiol Intv 2019, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....